We report a soluble isoform of mouse Fas, which is generated by alternative splicing of Fas mRNA to a newly identified exon located between exons 2 and 3 of the previously published Fas sequence. This splicing event creates a novel Fas transcript, Fas [3, with the potential to encode a truncated form of the extracellular domain, termed Fas B. In vitro, P815 mastocytoma cells transfected with Fas B become resistant to Fas ligand-induced apoptosis, and the resistance is mediated by a secreted product of the transfected cells. In vivo, Fas [3 mRNA expression is correlated inversely with apoptosis among subsets of intrahepatic T lymphocytes, a cell population in which activation-induced T cell apoptosis occurs. We propose that Fas B is a new cytokine that acts physiologically to limit apoptosis induced by Fas ligand.
Summary
We report a soluble isoform of mouse Fas, which is generated by alternative splicing of Fas mRNA to a newly identified exon located between exons 2 and 3 of the previously published Fas sequence. This splicing event creates a novel Fas transcript, Fas [3, with the potential to encode a truncated form of the extracellular domain, termed Fas B. In vitro, P815 mastocytoma cells transfected with Fas B become resistant to Fas ligand-induced apoptosis, and the resistance is mediated by a secreted product of the transfected cells. In vivo, Fas [3 mRNA expression is correlated inversely with apoptosis among subsets of intrahepatic T lymphocytes, a cell population in which activation-induced T cell apoptosis occurs. We propose that Fas B is a new cytokine that acts physiologically to limit apoptosis induced by Fas ligand.
S oluble isoforms of cell surface receptors regulate receptor function in a number of biological systems. Such soluble receptors most commonly retain ligand-binding activity and compete for ligand, thus inhibiting receptor function (1-3). Soluble receptor isoforms may be generated by proteolytic cleavage of the transmembrane form or by alternative mRNA splicing to generate distinct molecular species. In this report, we describe a soluble inhibitory isoform of the CD95/Fas molecule, which is generated by alternative splicing and is differentially expressed in T cell subsets undergoing apoptosis in vivo.
The Fas antigen (CD95) is important in activationinduced cell death of T lymphocytes (4, 5) and is widely expressed in the immune system and in nonlymphoid tissues (6, 7) . The susceptibility of cells to apoptosis induced by Fas ligation is regulated not only through the density of Fas on the cell surface, but also by other mechanisms that are poorly understood (8) (9) (10) . We have cloned a variant Fas transcript that encodes a truncated, soluble isoform that we term Fas B. Expression of Fas B inhibits apoptosis induced by Fas-Fas ligand (FasL) ~ interaction, and the differential expression of the two Fas isoforms in vivo is consistent with a role in controlling apoptosis in a subset of activated T cells in the liver.
Materials and Methods
Reverse Transcription (R T) PCR, Cloning, and Sequencing. Murine Fas message was amplified by PCR from total thymus cDNA 1 Abbreviations used in this paper: Etn, early transposable element; FasL, Fas ligand; IHL, intrahepatic T lymphocyte; RT, reverse transcription. using primers F1 (CGGGGATCCACCATGCTGTGGATCTGG-GCTG) and RL1 (GCGGAATTCGATATCACTCCAGACA-TTGTCC). Reactions contained 2.0 mM MgC12 and were run for 30 cycles of 1 min at 94~ 1 min at 58~ and 1.5 rain at 72~ The two resulting products were separated by agarose gel electrophoresis, cloned into pBluescript, and sequenced by the Taq-Dye-deoxy termination method, k-phage genomic clones of fas were isolated as described (11) , using a probe encoding the extracellular domain published for murine Fas (115 to 558 bp) (6) . The intronic regions surrounding exon 2A were sequenced from three of these clones using the exon 2A-specific primers 2AFOR (CGGGCGGCCGCGGACCAGTCTGATTCCTGG-CCACG) and 2AR (GCGGCGGCCGCCTGCCTGCAAGA-TGTGCAGG).
Antibodies and Flow Cytometry. The following antibodies were used: H57-597-Cy Chrome (anti-TCR CI~; Pharmingen, San Diego, CA) (12); RA3-3A1-FITC (TIB-146, anti-B220; kind gift fi:om Kim Bottomly, Yale University, New Haven, CT) (13); H129-19-FITC (anti-CD4; Gibco BRL, Gaithersburg, MD) (14); 53-6.7-Red 613 (anti-CD8ot; Gibco BILL) (15); and Jo-2-PE (anti-Fas; Pharmingen) (16) . FACS | staining was performed as described (17) . Data were acquired with a FACScan | flow cytometer, using FACScan | research software, and analyzed using Lysys 1.7 (instrument and software from Becton Dickinson & Co., Mountain View, CA).
Transfection. Fas B cDNA was obtained by RT-PCR using primers F1 and X3REV (GCGGCGGCCGCATGGGGCA-CAGGTTGGTG), digested with XbaI and SacI, then cloned into the same sites of the pSRot-72(N.1) eukaryotic expression vector. The pSRot-72(N.1) vector drives expression of the inserted sequence under control of the SV40 early promoter and the HTLV I 5' enhancer. The integrity of the insert was confirmed by sequencing as discussed earlier, and the vector DNA was electroporated into P815 cells as described (18) . From >700 neomycin-resistant clones, 200 were tested by PCR for presence of the cDNA insert. Of several dozen positive clones, four were chosen for further study. These clones expressed similar levels of Fas A, but different levels of Fas B, as tested by RT-PCR.
A FasL expression vector was made using the pSRot-72(N.1) vector and the FasL PCR product as described earlier for Fas B using primers FASLIGF1 (GCCTCTAGAGCCACCATGCAG-CAGCCCATG) and FASLIGR4 (GCGGAGCTCTTTTAA-AGCTTATACAAGC) (125 to 965 bp in Takahashi et al. [19] ). This vector was transfected into NIH-3T3 cells by using calcium phosphate precipitation as described (18) . Parallel to this transfection, NIH-3T3 cells were also transfected with the empty pSRot-72(N.1) vector, and all transfected 3T3 cells were selected in 0.5 mg/ml G418-supplemented medium. G418-resistant clones were tested for FasL expression by their ability to differentially kill wild-type but not lpr thymocytes. One clone was selected for expansion and use in further studies. All transfected cells were expanded and maintained in 0.5 mg/ml G418-supplemented medium until the passage before their use in experiments.
Isolation of lntrahepatic Lymphocytes. Intrahepatic T lymphocytes (IHLs) were isolated from livers of C57B1/6 mice by collagenase 1V digestion and metrizamide flotation as described (20) .
RNase Protection Analysis. Uniformly labeled riboprobes for
RNase protection were synthesized as described (11) at two different specific activities. A y-actin-specific probe, which protected a 105-bp fragment from the 3' untranslated region of the message, was synthesized using 800 fxM cold rCTP and 25 IzM UTP, of which 5 I-tM was supplied as ~-[32p]UTP. A Fas-specific probe, which protected a 121-bp fragment from Fas oL and a 272-bp band from Fas [3, was synthesized using 9 I~M each of rCTP and UTP, of which 5 ~M was supplied as c~-[32p]rCTP and o~-[32p]UTP. Protected fragments were separated by electrophoresis through a 5% polyacrylamide/8 M urea gel, and the dried gel was exposed to a phosphor-imaging screen for 4-6 d. Under the conditions used, the protected fragments frequently ran as doublet bands. In these cases, both bands were included in quantitation. The specific signal from each protected Fas band was divided by 1% of the specific signal from y-actin in that sample to determine Fas message intensity in "actin units."
Results

Cloning and Sequence of Fas B.
In an R T -P C R analysis of mouse Fas expression in thymocyte subsets, an amplified product of the expected size was consistently accompanied by a larger fragment that resulted from an alternative transcript of the Fas gene. The alternative transcript (which we term Fas ~3) arose from a 158-bp insertion between the second and third exons of the reported Fas sequence. A K-phage mouse genomic D N A library was screened with a plasmid containing the extracellular domain of the Fas sequence, and three clones were isolated in which the novel sequence could be detected by PCR. The sequence of this insertion, which we term exon 2A, and its surrounding intronic splice signals are shown in Fig. 1 A. The incorporation of exon 2A caused a frame shift in exon 3 of the gene, leading to a stop codon 27 bp into exon 3. The translated product of this message, Fas B, would be a truncated Fas protein containing a single cysteine-rich subdomain followed by a highly charged C O O H -t e r m i n a l tail. The mature Fas B polypeptide has a predicted molecular mass of 11 kD, with two potential N-linked glycosylation sites as well as O-linked sites.
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Soluble Mouse Fas we performed R T -P C R for Fas using cDNA from C57BI/6 mice or congenic B6-1pr thymocytes. Identical products were obtained from either template from reactions with a forward primer in exon 1 and a reverse primer in exon 2A.
W h e n reactions contained a forward primer in exon 2A and a reverse primer in exon 3 or at the 3' end of the coding region, however, we observed amplimers of the expected size only from the C57B1/6 template. No product was seen from the B6-1pr template. Similar results were obtained for M R L . M P -+ / + and MRL.MP-Ipr/Ipr template.
Because Fas R N A was spliced efficiently to exon 2A in both wild-type and lpr mice, but not from exon 2A to exon 3 in lpr mice, we conclude that the exon 2A sequence is 5' of the Etn insertion in Ipr (Fig. l B) . Function In Vitro. Such a molecule might be expected to act as a soluble competitor for the FasL, thereby inhibiting FasL-induced apoptosis. To test this hypothesis, P815 cells, which express endogenous transmembrane Fas (Fas A), but not Fas B, were transfected with a Fas B-encoding cDNA using the eukaryotic expression vector pSRcl-72(N.1). Four clones were selected for study. Clones 1B7 and 1D1 had low level expression of Fas B, as determined by competitive P C R , whereas clones 1D7 and 1Ell had "~ h i g h e r expression (data n o t shown). All clones expressed Fas A o n the cell surface, some m o r e a n d s o m e less t h a n w i l d -t y p e P815 (Fig. 2 A) . Fas B was therefore n o t simply interfering w i t h Fas A expression.
T o test the biological activity o f excess Fas B, these cells w e r e cultured o v e r n i g h t o n m o n o l a y e r s o f 3 T 3 fibroblasts that h a d b e e n transfected w i t h FasL (Fig. 2 B) . After o v e rn i g h t (18 h) coculture, viable P815 cells w e r e c o u n t e d b y nigrosin exclusion. Less t h a n 10% o f the w i l d -t y p e P815 cells survived the t r e a t m e n t w i t h FasL-positive 3 T 3 cells, w h e r e a s 2 0 -5 0 % o f clones 1B5 a n d 1D1, expressing Fas B at l o w levels, survived. A m o n g the h i g h expressing clones 1D7 a n d 1 E l l , 7 Because hepatocytes primarily express 13-actin rather than ~/-actin, quantitation of the total liver RNA sample is not shown. Quantitation was performed using a phosphorimager as described in Materials and Methods. ated apoptosis. The protection is caused by a soluble material, since supernatant from clone 1Ell protected parental P815 cells from apoptosis. We conclude that Fas B is secreted by the transfected cells as a soluble protein that inhibits apoptosis induced by Fas-FasL interaction.
Expression In Vivo. The messages encoding Fas A and Fas B were differentially expressed in different cell populations. The expressions of Fas oL and Fas 13 in R N A from various tissues were analyzed by RNase protection (Fig. 3,   1398 Soluble Mouse Fas A and B). Fas JB was more abundant in lymphoid tissues; 11-20% of the Fas message in thymus, LN, spleen, and bone marrow, but <5% of the total Fas message from liver, kidney, heart, and lung was in the Fas J3 form. Two T cell populations, thymocytes and IHLs, were selected for detailed analysis. Thymocyte subsets were tested because thymocytes are Fas positive (16, 23) , highly susceptible to apoptosis (24) (25) (26) , and differentially susceptible to Fas-mediated apoptosis (27) (28) (29) . Thymocytes were sorted by FACS | into subsets at different developmental stages based on TCR expression or CD4 and CD8 phenotype. Fas mRNA expression was very low in CD4-CD8-progenitor thymocytes, high in CD4+CD8 + immature cells, and lower on mature CD4+CD8 -and CD8+CD4 -cells, following the pattern of Fas expression on the membrane (29, 30) . The Fas ot/Fas 13 ratio, however, did not differ among these subsets ( Fig. 3  /3 ). We conclude that the recently reported exquisite sensitivity of CD4+CD8 + thymocytes to apoptosis induced by Fas ligation (27) (28) (29) is not caused by differential low expression of Fas B in these cells. In contrast to thymocytes, there is a strong case that Fas is important in the apoptosis of mature T cells and that this apoptosis occurs in the liver (4, 31). The two major subsets of intrahepatic T cells defined by B220 expression expressed Fas on the cell membrane at similar density (Fig. 4,  A and B ). These cell subsets had similar overall Fas mRNA levels but very different ratios of Fas a to Fas 13. The B220+CD4-CD8 -subset, in which N20% of the cells are in the process of apoptosis (20) , expressed a high level of Fas c~ with a low level of Fas 13. In contrast, the B220-subset, composed of both CD4 SP and CD8 SP cells (20) , expressed high levels of both Fas transcripts (Fig. 4, C and D) . Because the two populations express a similar amount of Fas A on the cell surface, their difference in Fas 13 expression probably accounts for their difference in apoptosis.
Discussion
While superantigen-induced deletion of mature CD4 + T cells results in apoptosis in the lymph nodes (32), peptide-driven deletion of CD8 + T cells leads to accumulation and apoptosis at a specific anatomical site: the liver (31). Activated T cells express an increased level of Fas on the cell membrane and are susceptible to Fas-induced apoptosis (5, 8, 10) . We propose that the liver is the site of activated T cell apoptosis because it is a site in which the T cells are exposed to FasL. This implies that all Fas-positive T cells among the IHL are vulnerable to FasL-induced apoptosis unless specifically protected. The CD4 + and CD8 + T cells in the liver appear to be protected by their elevated expression of Fas B. The function of these cells is unknown; their resistance to apoptosis suggests that unlike the B220 + CD4-CD8-cells, they are not proceeding along the peripheral deletion pathway. It is possible that, instead, they are the effectors of deletion.
A very different splice variant of the human Fas gene has been cloned by using PCR from T cells of a patient with systemic lupus erythematosus (33) . This cDNA resulted from deletion of the transmembrane region, leaving a sequence with the potential to encode a soluble molecule consisting of the extracellular domain direcdy linked to the signaling domain (sFas). The structure of sFas is highly unusual for a soluble receptor isoform. Whereas a number of other transmembrane receptors (for example, IL-7 and G-CSF) generate soluble isoforms by splicing out of the transmembrane region, such deletions cause frameshifts or stop codons, as we describe here for Fas B (3, 34) . An ELISA with anti-Fas antibody showed that a form of soluble Fas was present in the sera of some lupus patients, but whether this is in fact transmembrane-deficient sFas, a human equivalent of murine Fas B, or simply Fas A shed from the surface of dying cells remains to be determined. The expression pattern of transmembrane-deficient sFas in normal human T cells has not yet been defined. It is possible that both humans and mice regulate Fas-mediated apoptosis through soluble isoforms but generate these in completely different ways. It is also possible that sFas and Fas B exist in both species but perform different functions. A recent study of mouse Fas protein expression by immunoprecipitation showed three molecular species, which may correspond to Fas A, Fas B, and sFas (35) .
The abnormal Fas mRNA species generated in mice with the lpr mutation have the potential to encode truncated forms of Fas similar to Fas B (22) . The insertion of the Etn transposon in this mutation leads to frequent splicing of RNA to a site just 5' of the LTR; this generates truncated messages that use the Etn poly A addition site and can be translated (22 
